0000899243-22-008015.txt : 20220228
0000899243-22-008015.hdr.sgml : 20220228
20220228134212
ACCESSION NUMBER: 0000899243-22-008015
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211214
FILED AS OF DATE: 20220228
DATE AS OF CHANGE: 20220228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GARDINER SANDRA A.
CENTRAL INDEX KEY: 0001218574
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37744
FILM NUMBER: 22687019
MAIL ADDRESS:
STREET 1: CUTERA, INC.
STREET 2: 3240 BAYSHORE BOULEVARD
CITY: BRISBANE
STATE: CA
ZIP: 94005
FORMER NAME:
FORMER CONFORMED NAME: GARDINER SANDRA
DATE OF NAME CHANGE: 20030212
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Pulse Biosciences, Inc.
CENTRAL INDEX KEY: 0001625101
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 465696597
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3957 POINT EDEN WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
BUSINESS PHONE: 510-906-4600
MAIL ADDRESS:
STREET 1: 3957 POINT EDEN WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
FORMER COMPANY:
FORMER CONFORMED NAME: Electroblate, Inc.
DATE OF NAME CHANGE: 20141113
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-12-14
0
0001625101
Pulse Biosciences, Inc.
PLSE
0001218574
GARDINER SANDRA A.
C/O PULSE BIOSCIENCES, INC.
3957 POINT EDEN WAY
HAYWARD
CA
94545
0
1
0
0
CFO & EVP Admin. and Finance
Stock Option (right to buy)
13.94
2021-12-14
4
A
0
25961
0.00
A
2021-12-14
2029-11-18
Common Stock
25961
51922
D
On November 18, 2019, the reporting person was granted an option to purchase 103,842 shares of the issuer's common stock. The option vests based upon the achievement of performance objectives, with vesting targets no less than 25% vesting per year upon achievement of said objectives established by the Compensation Committee of the issuer, subject to the reporting person's continued service through each vesting date. The performance objectives for 2021 were met, resulting in the vesting of the option as to 25,961 shares.
Represents the options which vested on the 2020 vesting date and the options which vested on the 2021 vesting date.
/s/ Kenneth B. Stratton, as Attorney-in-Fact
2022-02-28